Laba, Tracey-Lea http://orcid.org/0000-0002-5182-9092
Reddel, Helen K.
Zwar, Nicholas J.
Marks, Guy B.
Roughead, Elizabeth
Flynn, Anthony
Goldman, Michele
Heaney, Aine
Lembke, Kirsty
Jan, Stephen
Funding for this research was provided by:
National Health and Medical Research Council (GNT1077204, APP1110230, APP111943, APP1110139)
Article History
First Online: 27 October 2018
Compliance with Ethical Standards
:
: Ethical approval was granted by the University of New South Wales Human Research Advisory Panel Ethics Committee (Approval number # HREAP 2014-7-34). All procedures were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants.
: The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
: This study was funded by a National Health and Medical Research Council (NHMRC) partnership grant (GNT1077204) with matching funding (including in-kind in the form of staff time) from Asthma Foundation NSW and Asthma Australia Inc. (both now part of the new merged Asthma Australia Limited) and from NPS MedicineWise. TL is supported by a NHMRC Early Career (Sidney Sax) Fellowship (APP 1110230). SJ is supported by an NHMRC Principal Research Fellowship (APP111943). ER is supported by an NHMRC Senior Principal Research Fellowship (APP1110139).
: HKR reports receiving independent research grants and study inhalers from GlaxoSmithKline and AstraZeneca, honoraria from AstraZeneca, GlaxoSmithKline, Merck and Novartis for participation on a data safety monitoring board, and honoraria for providing independent medical advice on advisory boards or steering committees from AstraZeneca, GlaxoSmithKline, Novartis and Boehringer Ingelheim, and for providing independent medical education at symposia funded by AstraZeneca, GlaxoSmithKline, Novartis, Teva, Boehringer Ingelheim and Mundipharma. HKR is Chair of the Global Initiative for Asthma (GINA) Scientific Committee and a member of the Australian Asthma Handbook Guidelines Committee. GBM reports non-financial support from GlaxoSmithKline PLC, grants from AstraZeneca, outside the submitted work. MG reports income from multiple pharmaceutical and device manufacturers outside the submitted work, specifically, non-financial support from Bird Healthcare, non-financial support from GSK, non-financial support from Astra Zeneca, grants from GSK, grants from Astra Zeneca, grants from Sanofi, grants from Bayer, and grants from Cipla. TL, NJZ, ER, AF, AH, KL, and SJ have no conflicts of interest related to the contents of this article.
: All authors contributed to the conception or design of the work; acquisition, analysis or interpretation of data for the work; drafting or critical revision for intellectual content; final approval of the submitted version; and are accountable for all aspects of the work.